# XCH (XCHG Limited) - SEC EDGAR Financial Statements

> XCHG Limited reported $25.10M in revenue and a net loss of $32.50M for the fiscal year ended December 31, 2025 (down 40.5% year over year), with a 46.2% gross margin and a -129.9% operating margin.

- Canonical: https://convexityos.com/fundamentals/XCH
- Markdown: https://convexityos.com/fundamentals/XCH.md
- SEC CIK: 0001979887
- Reporting currency: USD
- Latest filing period: December 31, 2025
- Last synced: Nov 21, 2026, 05:04 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001979887&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $25.10M | -40.5% YoY |
| Operating Income | FY 2025 | -$32.62M | -129.9% margin |
| Net Income | FY 2025 | -$32.50M | -129.5% net margin |
| Diluted EPS | FY 2025 | -- | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Dec 31, 2025 | $11.39M | Total debt: $8.17M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Revenue** | $25.10M | $42.20M | $38.51M | $29.42M |
| Cost of Revenue | $13.50M | $20.98M | $20.94M | $18.72M |
| **Gross Profit** | $11.60M | $21.22M | $17.57M | $10.70M |
| Research & Development | $7.07M | $12.16M | $4.06M | $2.82M |
| Selling, General & Admin | $37.26M | $21.13M | $20.46M | $6.26M |
| Total Operating Expenses | $44.33M | $33.29M | $24.52M | $9.08M |
| **Operating Income** | -$32.62M | -$12.03M | -$6.52M | $1.65M |
| **EBITDA** | -$32.34M | -$11.80M | -$6.31M | $1.79M |
| Interest Income | $200K | $158K | $101K | $201K |
| Interest Expense | $215K | $213K | $194K | $67K |
| Income Before Tax | -$32.50M | -$11.94M | -$8.08M | $1.60M |
| Income Tax Expense | -- | -- | -- | -$12K |
| **Net Income** | -$32.50M | -$11.94M | -$8.08M | $1.61M |
| Basic EPS | -- | -- | -$0.01 | -- |
| **Diluted EPS** | -- | -- | -$0.01 | -- |
| Basic Shares Outstanding | 2.80B | 1.29B | 713.3M | 656.2M |
| Diluted Shares Outstanding | 2.80B | 1.29B | 713.3M | 656.2M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $11.39M | $26.77M | $15.66M |
| **Cash & Short-Term Investments** | $11.39M | $26.77M | $15.66M |
| Accounts Receivable, Net | $7.01M | $11.24M | $12.50M |
| Inventory | $9.43M | $7.68M | $6.66M |
| **Total Current Assets** | $37.11M | $54.41M | $39.75M |
| Property, Plant & Equipment, Net | $1.97M | $969K | $576K |
| Intangible Assets | -- | -- | $27K |
| Long-Term Investments | $107K | $104K | $106K |
| Other Non-Current Assets | $1.71M | -- | -- |
| **Total Non-Current Assets** | $5.56M | $2.73M | $1.21M |
| **Total Assets** | $42.67M | $57.14M | $40.96M |
| Accounts Payable | $6.73M | $7.67M | $5.75M |
| Short-Term Debt | $6.40M | $8.81M | $5.56M |
| Deferred Revenue (Current) | $4.07M | $3.23M | $1.33M |
| Other Current Liabilities | $164K | $126K | -- |
| **Total Current Liabilities** | $23.54M | $26.19M | $30.73M |
| Other Non-Current Liabilities | $89K | $167K | $80K |
| **Total Non-Current Liabilities** | $1.26M | $1.44M | $252K |
| **Total Liabilities** | $24.80M | $27.63M | $30.98M |
| **Total Debt (incl. Leases)** | $8.17M | $10.39M | $6.03M |
| Common Stock | -- | -- | $8.1K |
| Retained Earnings | -$84.88M | -$52.37M | -$40.43M |
| Accumulated Other Comp. Income | $1.89M | $1.98M | $1.82M |
| **Total Stockholders' Equity** | $17.87M | $29.51M | -$30.04M |
| Total Equity | $17.87M | $29.51M | -$30.04M |

### Balance Sheet (Quarterly)

| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $11.39M | $26.77M | $15.66M |
| **Cash & Short-Term Investments** | $11.39M | $26.77M | $15.66M |
| Accounts Receivable, Net | $7.01M | $11.24M | $12.50M |
| Inventory | $9.43M | $7.68M | $6.66M |
| **Total Current Assets** | $37.11M | $54.41M | $39.75M |
| Property, Plant & Equipment, Net | $1.97M | $969K | $576K |
| Intangible Assets | -- | -- | $27K |
| Long-Term Investments | $107K | $104K | $106K |
| Other Non-Current Assets | $1.71M | -- | -- |
| **Total Non-Current Assets** | $5.56M | $2.73M | $1.21M |
| **Total Assets** | $42.67M | $57.14M | $40.96M |
| Accounts Payable | $6.73M | $7.67M | $5.75M |
| Short-Term Debt | $6.40M | $8.81M | $5.56M |
| Deferred Revenue (Current) | $4.07M | $3.23M | $1.33M |
| Other Current Liabilities | $164K | $126K | -- |
| **Total Current Liabilities** | $23.54M | $26.19M | $30.73M |
| Other Non-Current Liabilities | $89K | $167K | $80K |
| **Total Non-Current Liabilities** | $1.26M | $1.44M | $252K |
| **Total Liabilities** | $24.80M | $27.63M | $30.98M |
| **Total Debt (incl. Leases)** | $8.17M | $10.39M | $6.03M |
| Common Stock | -- | -- | $8.1K |
| Retained Earnings | -$84.88M | -$52.37M | -$40.43M |
| Accumulated Other Comp. Income | $1.89M | $1.98M | $1.82M |
| **Total Stockholders' Equity** | $17.87M | $29.51M | -$30.04M |
| Total Equity | $17.87M | $29.51M | -$30.04M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$32.50M | -$11.94M | -$8.08M | $1.61M |
| Depreciation & Amortization | $275K | $233K | $203K | $138K |
| Stock-Based Compensation | $20.94M | $7.03M | $7.46M | -- |
| Change in Receivables | $4.72M | $668K | -$5.06M | -$3.60M |
| Change in Inventory | -$1.84M | -$1.26M | -$663K | -$3.38M |
| Change in Payables | -$2.12M | $2.42M | -$860K | $4.09M |
| **Operating Cash Flow** | -$7.53M | -$7.20M | -$5.58M | $849K |
| **Investing Cash Flow** | -$1.50M | -$534K | $2.27M | $1.22M |
| Common Stock Issued | -- | $19.09M | -- | -- |
| **Financing Cash Flow** | -$4.33M | $19.15M | $10.74M | $2.28M |
| **Net Change in Cash** | -$12.87M | $11.08M | $7.02M | $3.84M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Gross Margin** | 46.2% | 50.3% | 45.6% | 36.4% |
| **Operating Margin** | -129.9% | -28.5% | -16.9% | 5.6% |
| **Net Profit Margin** | -129.5% | -28.3% | -21.0% | 5.5% |
| Return on Equity (ROE) | -181.9% | -40.5% | -- | -- |
| Return on Assets (ROA) | -76.2% | -20.9% | -19.7% | -- |
| Current Ratio | 1.58x | 2.08x | 1.29x | -- |
| Quick Ratio | 1.18x | 1.78x | 1.08x | -- |
| Debt to Equity | 0.46x | 0.35x | -- | -- |
| **Revenue Growth (YoY)** | -40.5% | +9.6% | +30.9% | -- |
| Gross Profit Growth (YoY) | -45.4% | +20.8% | +64.2% | -- |
| Operating Income Growth (YoY) | -- | -- | -493.8% | -- |
| **Net Income Growth (YoY)** | -- | -- | -602.1% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -756.9% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
